FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081900774> ?p ?o ?g. }

• W3081900774 endingPage "e2294" @default.
• W3081900774 startingPage "e2286" @default.
• W3081900774 abstract "Objective To test ketamine infusion efficacy in the treatment of super-refractory status epilepticus (SRSE), we studied patients with SRSE who were treated with ketamine retrospectively. We also studied the effect of high doses of ketamine on brain physiology as reflected by invasive multimodality monitoring (MMM). Methods We studied a consecutive series of 68 patients with SRSE who were admitted between 2009 and 2018, treated with ketamine, and monitored with scalp EEG. Eleven of these patients underwent MMM at the time of ketamine administration. We compared patients who had seizure cessation after ketamine initiation to those who did not. Results Mean age was 53 ± 18 years and 46% of patients were female. Seizure burden decreased by at least 50% within 24 hours of starting ketamine in 55 (81%) patients, with complete cessation in 43 (63%). Average dose of ketamine infusion was 2.2 ± 1.8 mg/kg/h, with median duration of 2 (1–4) days. Average dose of midazolam was 1.0 ± 0.8 mg/kg/h at the time of ketamine initiation and was started at a median of 0.4 (0.1–1.0) days before ketamine. Using a generalized linear mixed effect model, ketamine was associated with stable mean arterial pressure (odds ratio 1.39, 95% confidence interval 1.38–1.40) and with decreased vasopressor requirements over time. We found no effect on intracranial pressure, cerebral blood flow, or cerebral perfusion pressure. Conclusion Ketamine treatment was associated with a decrease in seizure burden in patients with SRSE. Our data support the notion that high-dose ketamine infusions are associated with decreased vasopressor requirements without increased intracranial pressure. Classification of evidence This study provides Class IV evidence that ketamine decreases seizures in patients with SRSE." @default.
• W3081900774 created "2020-09-08" @default.
• W3081900774 creator A5000426332 @default.
• W3081900774 creator A5007426651 @default.
• W3081900774 creator A5008303654 @default.
• W3081900774 creator A5017801761 @default.
• W3081900774 creator A5019948345 @default.
• W3081900774 creator A5024690923 @default.
• W3081900774 creator A5030064680 @default.
• W3081900774 creator A5033495424 @default.
• W3081900774 creator A5034657440 @default.
• W3081900774 creator A5040410466 @default.
• W3081900774 creator A5047790773 @default.
• W3081900774 creator A5069884214 @default.
• W3081900774 creator A5075703955 @default.
• W3081900774 creator A5080823003 @default.
• W3081900774 creator A5090876028 @default.
• W3081900774 date "2020-09-01" @default.
• W3081900774 modified "2023-10-16" @default.
• W3081900774 title "Ketamine to treat super-refractory status epilepticus" @default.
• W3081900774 cites W1515409634 @default.
• W3081900774 cites W1559214144 @default.
• W3081900774 cites W1856414226 @default.
• W3081900774 cites W1966729788 @default.
• W3081900774 cites W1972491904 @default.
• W3081900774 cites W1973522012 @default.
• W3081900774 cites W1973912400 @default.
• W3081900774 cites W1977172112 @default.
• W3081900774 cites W1992916966 @default.
• W3081900774 cites W1994862799 @default.
• W3081900774 cites W2018537604 @default.
• W3081900774 cites W2022264741 @default.
• W3081900774 cites W2028257602 @default.
• W3081900774 cites W2029569324 @default.
• W3081900774 cites W2034946412 @default.
• W3081900774 cites W2047273182 @default.
• W3081900774 cites W2059208446 @default.
• W3081900774 cites W2084468981 @default.
• W3081900774 cites W2105580342 @default.
• W3081900774 cites W2117858464 @default.
• W3081900774 cites W2133111689 @default.
• W3081900774 cites W2134004558 @default.
• W3081900774 cites W2161070714 @default.
• W3081900774 cites W2165740328 @default.
• W3081900774 cites W2252496421 @default.
• W3081900774 cites W2426675879 @default.
• W3081900774 cites W2511160365 @default.
• W3081900774 cites W2909615847 @default.
• W3081900774 cites W2956808619 @default.
• W3081900774 doi "https://doi.org/10.1212/wnl.0000000000010611" @default.
• W3081900774 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7713785" @default.
• W3081900774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32873691" @default.
• W3081900774 hasPublicationYear "2020" @default.
• W3081900774 type Work @default.
• W3081900774 sameAs 3081900774 @default.
• W3081900774 citedByCount "46" @default.
• W3081900774 countsByYear W30819007742021 @default.
• W3081900774 countsByYear W30819007742022 @default.
• W3081900774 countsByYear W30819007742023 @default.
• W3081900774 crossrefType "journal-article" @default.
• W3081900774 hasAuthorship W3081900774A5000426332 @default.
• W3081900774 hasAuthorship W3081900774A5007426651 @default.
• W3081900774 hasAuthorship W3081900774A5008303654 @default.
• W3081900774 hasAuthorship W3081900774A5017801761 @default.
• W3081900774 hasAuthorship W3081900774A5019948345 @default.
• W3081900774 hasAuthorship W3081900774A5024690923 @default.
• W3081900774 hasAuthorship W3081900774A5030064680 @default.
• W3081900774 hasAuthorship W3081900774A5033495424 @default.
• W3081900774 hasAuthorship W3081900774A5034657440 @default.
• W3081900774 hasAuthorship W3081900774A5040410466 @default.
• W3081900774 hasAuthorship W3081900774A5047790773 @default.
• W3081900774 hasAuthorship W3081900774A5069884214 @default.
• W3081900774 hasAuthorship W3081900774A5075703955 @default.
• W3081900774 hasAuthorship W3081900774A5080823003 @default.
• W3081900774 hasAuthorship W3081900774A5090876028 @default.
• W3081900774 hasBestOaLocation W30819007742 @default.
• W3081900774 hasConcept C118552586 @default.
• W3081900774 hasConcept C121332964 @default.
• W3081900774 hasConcept C126322002 @default.
• W3081900774 hasConcept C142424586 @default.
• W3081900774 hasConcept C154281038 @default.
• W3081900774 hasConcept C157767197 @default.
• W3081900774 hasConcept C2776814716 @default.
• W3081900774 hasConcept C2777341932 @default.
• W3081900774 hasConcept C2778000748 @default.
• W3081900774 hasConcept C2778186239 @default.
• W3081900774 hasConcept C2780795376 @default.
• W3081900774 hasConcept C42219234 @default.
• W3081900774 hasConcept C44249647 @default.
• W3081900774 hasConcept C71924100 @default.
• W3081900774 hasConcept C87355193 @default.
• W3081900774 hasConceptScore W3081900774C118552586 @default.
• W3081900774 hasConceptScore W3081900774C121332964 @default.
• W3081900774 hasConceptScore W3081900774C126322002 @default.
• W3081900774 hasConceptScore W3081900774C142424586 @default.
• W3081900774 hasConceptScore W3081900774C154281038 @default.
• W3081900774 hasConceptScore W3081900774C157767197 @default.
• W3081900774 hasConceptScore W3081900774C2776814716 @default.

• next